Literature DB >> 15647743

Deficiency of PAR-2 gene increases acute focal ischemic brain injury.

Guang Jin1, Takeshi Hayashi, Junichi Kawagoe, Toshiaki Takizawa, Tetsuya Nagata, Isao Nagano, Mikio Syoji, Koji Abe.   

Abstract

The expression profile of the protease-activated receptor-2 (PAR-2) and effects of PAR-2 gene knockout (PAR-2 KO) on the infarct size were investigated after 60 minutes of transient middle cerebral artery occlusion (tMCAO) in mice in relation to phosphorylated extracellular signal-regulated kinase (p-ERK) and astrocyte activation. PAR-2 was normally distributed mainly in neurons of the central nervous system (CNS), and strongly upregulated at 8-24 hours after tMCAO. Deficiency of PAR-2 gene significantly increased the infarct volume and the number of TUNEL-positive cells at 24 hours of reperfusion. The strong neuronal expression of p-ERK was induced at 5 minutes as a peak after reperfusion in wild-type mice, but the signal change was significantly reduced in PAR-2 KO mice. Astroglial activation was also greatly inhibited at 24 hours after tMCAO in PAR-2 KO mice. These results show that the deficiency of PAR-2 gene increases the acute ischemic cerebral injury associating with suppression of neuronal ERK activation and reactive astroglial activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647743     DOI: 10.1038/sj.jcbfm.9600021

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  20 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

2.  Protease-activated receptor 2 deficiency reduces cardiac ischemia/reperfusion injury.

Authors:  Silvio Antoniak; Mauricio Rojas; Denise Spring; Tara A Bullard; Edward D Verrier; Burns C Blaxall; Nigel Mackman; Rafal Pawlinski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-08-19       Impact factor: 8.311

3.  Genetic targeting of protease activated receptor 2 reduces inflammatory astrogliosis and improves recovery of function after spinal cord injury.

Authors:  Maja Radulovic; Hyesook Yoon; Jianmin Wu; Karim Mustafa; Michael G Fehlings; Isobel A Scarisbrick
Journal:  Neurobiol Dis       Date:  2015-08-24       Impact factor: 5.996

4.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

5.  Activated microglia enhance neurogenesis via trypsinogen secretion.

Authors:  Angeliki M Nikolakopoulou; Ranjan Dutta; Zhihong Chen; Robert H Miller; Bruce D Trapp
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-06       Impact factor: 11.205

Review 6.  Serine proteases, serine protease inhibitors, and protease-activated receptors: roles in synaptic function and behavior.

Authors:  Antoine G Almonte; J David Sweatt
Journal:  Brain Res       Date:  2011-06-24       Impact factor: 3.252

7.  Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.

Authors:  Dennis J Grab; Jose C Garcia-Garcia; Olga V Nikolskaia; Yuri V Kim; Amanda Brown; Carlos A Pardo; Yongqing Zhang; Kevin G Becker; Brenda A Wilson; Ana Paula C de A Lima; Julio Scharfstein; J Stephen Dumler
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

8.  Presenilin 1 promotes trypsin-induced neuroprotection via the PAR2/ERK signaling pathway. Effects of presenilin 1 FAD mutations.

Authors:  Angeliki M Nikolakopoulou; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Neurobiol Aging       Date:  2016-03-04       Impact factor: 4.673

9.  Neuroprotective effect of protease-activated receptor-2 in the hypoxia-induced apoptosis of rat RGC-5 cells.

Authors:  Yanli Peng; Jiaping Zhang; Haiwei Xu; Jianrong He; Xi Ying; Yi Wang
Journal:  J Mol Neurosci       Date:  2012-09-05       Impact factor: 3.444

Review 10.  The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders.

Authors:  Trevor Bushell
Journal:  J Physiol       Date:  2007-03-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.